Crossmark

Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits

Crossref DOI link: https://doi.org/10.1007/s13555-021-00560-6

Published Online: 2021-06-09

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lebwohl, Mark G. https://orcid.org/0000-0002-4705-5303
Tanghetti, Emil A. https://orcid.org/0000-0002-1115-3219
Stein Gold, Linda https://orcid.org/0000-0002-2758-1605
Del Rosso, James Q. https://orcid.org/0000-0003-4215-7340
Gilyadov, Nelly K.

Jacobson, Abby
License Information

Text and Data Mining valid from 2021-06-09

Version of Record valid from 2021-06-09
More Information

Article History

Received: 7 April 2021

First Online: 9 June 2021